There are many people involved in work on both BrainGate specifically and brain-computer interfaces (BMIs) in general. Below is a list of some of the key contributors to the field:
Mr. Stibel has worked with Drs. Donoghue and Hatsopoulos on potential uses of BrainGate and brain-machine interfaces. He has also worked as part of the founding Board of ZEO, a sleep research company that has a number of commercial products that utilize EEG technology to predict brain activity. Stibel is currently President and a member of the Board of Directors of Web.com (NASDAQ: WWWW), a leading provider of online marketing services for small businesses. Prior to Web.com, Mr. Stibel was part of the founding management team at United Online (NASDAQ: UNTD), a technology company that owns and operates leading web services, including NetZero, Juno, and Classmates.com. Prior to United Online, Mr. Stibel was founder, Chairman, and CEO of Simpli.com, a search and marketing technology company currently owned by ValueClick (NASDAQ: VCLK). In addition to BrainGate, he serves on the board of directors for Web.com, Autobytel (NASDAQ: ABTL) and several private companies, including The Search Agency and EdgeCast. He also serves on the Board of Brown University's Entrepreneurship Program and Tufts University's Gordon Center for Leadership. Mr. Stibel has authored numerous academic and trade articles on a variety of subjects and is the named inventor on the US patent for search engine interfaces. He received a Master's degree from Brown University and studied Business and Brain Science at MIT's Sloan School of Management and at Brown University, where he was a Brain and Behavior Fellow.
Dr. John P. Donoghue, Ph.D.
Dr. Donoghue is currently the Henry Merritt Wriston Professor at Brown University. Since 1991, Dr. Donoghue has been Chairman of the Department of Neuroscience and since 1998 he has served as Executive Director of the Brain Science Program at Brown University. Dr. Donoghue has performed over 20 years of research on brain computer interfaces and his laboratory is internationally recognized as a leader in this field. His research has been funded by the National Institute of Health ("NIH"), the National Science Foundation ("NSF"), and the Defense Advanced Research Projects Agency ("DARPA"), as well as private foundations. Dr. Donoghue has over 50 publications, including in top journals such as Nature, Science and the Journal of Neuroscience and he has served on many external advisory panels, including those for the NIH's Neurology and Mental Health institutes and the space medicine panel of the National Aeronautics and Space Administration ("NASA"). Dr. Donoghue received an A.B. from Boston University in 1971, an M.S. in Anatomy from the University of Vermont in 1976 and a Ph.D. in Neuroscience from Brown University in 1979. Dr. Donoghue co-founded Cyberkinetics Neurotechnology Systems in 2001. http://donoghue.neuro.brown.edu/
Dr. Nicholas G. "Nicho" Hatsopoulos, Ph.D.
Dr. Hatsopoulos is currently an Associate Professor at the University of Chicago. Dr. Hatsopoulos is also Chairman of the Computational Neuroscience graduate program. He is currently running a laboratory with five graduate students, two postdoctoral fellows, and several technicians which is funded in part by the National Institutes of Health. From January 1998 to December 2001, Dr. Hatsopoulos was an Assistant Professor of Research in the Department of Neuroscience at Brown University. Dr. Hatsopoulos completed two postdoctoral research fellowships, one in the Department of Neuroscience at Brown University and the other in the Computational Neuroscience Program at the California Institute of Technology. Dr. Hatsopoulos completed his B.A. in Physics from Williams College in 1984, his M.S. in Psychology in 1991 and his Ph.D. in Cognitive Science from Brown University in 1992. In 2001, he co-founded a company, Cyberkinetics Neurotechnology Systems, which is taking the basic scientific research he and his colleagues have conducted to develop neural prosthesis technology to assist people with severe motor disabilities. http://pondside.uchicago.edu/oba/faculty/Hatsopoulos/lab/
Ms. Hackett has worked with Drs. Donoghue and Hatsopoulos on potential uses of BrainGate and brain-machine interfaces. She has also consulted for ZEO, a sleep research company that has a number of commercial products that utilize EEG technology to predict brain activity. Ms. Hackett has more than 20 years experience in strategic planning, marketing, sales, advertising, product and brand development. Ms. Hackett additionally leads marketing efforts at FourSpots.com, a leading technology start-up in the self-serve video advertising industry. Previously, Ms. Hackett served as Chief Marketing Officer for Web.com, a leading provider of websites and web services for small businesses, where she led the company's marketing and sales operations in a successful turnaround and sale. Hackett was also SVP and Chief Marketing Officer for CareerBuilder Inc., a leading online and print recruitment company. Prior to CareerBuilder, she was Senior Vice President of Marketing and Communications at HeadHunter.NET and helped take the company public in 1999. Hackett also served as Senior Vice President of Marketing and Advertising for TBS Superstation and has held several roles in advertising and marketing management at Fox, CBS, ABC and independent television stations, where she won an Emmy for her efforts.
Leigh Hochberg, M.D., Ph.D.
Dr. Hochberg is the Principal Investigator for the feasibility study of the BrainGate System in persons with ALS or other forms of motor neuron disease. Dr. Hochberg was a key contributor to the creation of the clinical Protocol for the current trial. He received his M.D. and Ph.D. degrees from Emory University. He completed his neurology residency and was a Chief Resident at MGH and Brigham & Women’s Hospitals (BWH). Dr. Hochberg is trained in stroke/neurocritical care, is on the Neurology staff at MGH and BWH, and consults at the Spaulding Rehabilitation Center. http://www.massgeneral.org/stopstroke/bioAll.aspx?physician=Leigh_R_Hochberg&type=Physicians
Robert Brown, Jr., M.D., D. Phil.
Dr. Brown is Professor of Neurology at Harvard Medical School, a member of the Institute of Medicine and Director of the Day Neuromuscular Laboratory and Muscular Dystrophy Association clinic at Massachusetts General Hospital (MGH). The Day Laboratory of Neuromuscular Research was founded in 1984 by Dr. Brown and has become an internationally recognized center for research and clinical care in neuromuscular diseases.
Merit Cudkowicz, M.D.
Dr. Cudkowicz is an Associate Professor at Harvard Medical School. She is trained in Neurology and Experimental Therapeutics with a focus in neurodegenerative disorders. Dr. Cudkowicz is an Associate Professor at Harvard Medical School. Dr. Cudkowicz co-directs the MGH ALS clinic and the Neurology Clinical Trials Unit at MGH and Partners HealthCare System. She is leading several multi-center clinical trials in ALS.
Lisa Krivickas, M.D.
Dr. Krivickas is Associate Chief of Physical Medicine & Rehabilitation at MGH and practices at the Spaulding Rehabilitation Hospital. She received her M.D. degree from Harvard University and completed her Physical Medicine & Rehabilitation Fellowship at the Department of Neurology at Cleveland Clinic. She currently serves on the Board of scientific advisors for the Massachusetts ALS Association Chapter.
Surgenor is President, Chief Executive Officer and Director of CyberKinetics, Inc., a commercial developer of brain-machine interfaces.. Mr. Surgenor joined Cyberkinetics in 2003 from Haemonetics Corporation, a medical device company located in Braintree, MA where he was Executive Vice President with responsibility for business development, global marketing, quality assurance and regulatory affairs from 1999- 2003. While at Haemonetics, Mr. Surgenor was an active member of the investor relations team. From 1994 -1999, Mr. Surgenor was President of Genzyme Tissue Repair, the cell therapy division of Genzyme Corporation located in Cambridge, MA. While at Genzyme Tissue Repair, Mr. Surgenor led successful public offerings which raised approximately $100 million. Previously, Mr. Surgenor was Executive Vice President and Chief Financial Officer of BioSurface Technology, Inc. and also held various positions in operations at Integrated Genetics. Mr. Surgenor received a B.A. in Biochemistry from Williams College in 1981 and an M.B.A. from Harvard Business School in 1987.
Nicolelis is best known for his pioneering work in "reading monkey thought". He and his colleagues implanted electrode arrays into a monkey's brain that were able to detect the monkey's motor intent and thus able to control reaching and grasping movements performed by a robotic arm. He received an M.D. degree from University of São Paulo Medical School in 1984. He got a Phd in 1988/89 at the Institute of Biomedical Science, University of São Paulo. Currently, Nicolelis is a Professor of Neurobiology, Biomedical Engineering and Psychological and Brain Sciences, and he and Craig Henriquez, a Professor in Biomedical Engineering, serve as Co-Directors of the Center for Neuroengineering, Duke University Medical Center (since 2001). He is also currently involved with setting up an international neuroscience research centre in Natal, state of Rio Grande do Norte, the International Institute for Neuroscience of Natal (IINN). In 2004, he was chosen by the journal Science as one of the 100 most influential scientists of the year. He also appears in the 2004 Scientific American listing of most influential research leaders of the year. http://www.nicolelislab.net/
Dr. Theodore W. Berger
The research of Dr. Berger involves the complementary use of experimental and theoretical approaches to developing biologically constrained mathematical models of mammalian neural systems. The focus of the majority of current research is the hippocampus, a neural system essential for learning and memory functions. http://www.neural-prosthesis.com/
Prof. Jerry Pine
Dr. Pine is Professor of Physics currently residing in the division of Biology, has been contributing to the biophysics/neurobiology field for over 20 years. Professor Pine and his collaborators have developed a number of new technologies for studying neural systems. Examples include an x-ray microscope for living cells, multi-electrode cell culture chambers, fiber-optic photodiode arrays and high-speed CCD cameras for imaging of neural activity, and silicon probes for long-term interfacing of neural tissue with external electronics. He is currently leading the Pinelab to develop the neurochip. http://www.its.caltech.edu/~pinelab/new_pinelab_page/pine_lab.htm#jerry